Improve diagnostic accuracy following routine C-peptide testing in individuals with a clinician diagnosis of Type 1 diabetes

被引：0
|
作者：
Foteinopoulou, E. [1 ]
Clarke, C. [1 ]
Pattenden, R. [1 ]
McKnight, J. [1 ]
Strachan, M. W. J. [1 ]
机构：
[1] Western Gen Hosp, Edinburgh, Midlothian, Scotland
来源：
SCOTTISH MEDICAL JOURNAL | 2019年 / 64卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：NP65 / NP66
页数：2
相关论文
共 50 条
  • [1] Impact of routine C-peptide screening in individuals with a clinician diagnosis of type 1 diabetes
    Foteinopoulou, E.
    Clarke, C.
    Pattenden, R.
    McKnight, J.
    Strachan, M. W. J.
    DIABETOLOGIA, 2018, 61 : S152 - S153
  • [2] Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetes
    Foteinopoulou, Evgenia
    Clarke, Catriona A. L.
    Pattenden, Rebecca J.
    Ritchie, Stuart A.
    McMurray, Emily M.
    Reynolds, Rebecca M.
    Arunagirinathan, Ganesan
    Gibb, Fraser W.
    McKnight, John A.
    Strachan, Mark W. J.
    DIABETIC MEDICINE, 2021, 38 (07)
  • [3] Comment on 'impact of routine Clinic Measurement of random Serum c-peptide in people with a Clinician Diagnosis of type 1 diabetes'
    Patel, Shivani K.
    Fourlanos, Spiros
    Greenfield, Jerry R.
    DIABETIC MEDICINE, 2021, 38 (04)
  • [4] Measurement of c-peptide in patients with a clinical diagnosis of Type 1 diabetes improves diagnostic accuracy and may allow cessation of insulin therapy in some individuals
    Foteinopoulou, E.
    Clarke, C.
    Pattenden, R.
    McKnight, J.
    Strachan, M. W. J.
    DIABETIC MEDICINE, 2019, 36 : 7 - 7
  • [5] Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes
    Roshandel, Delnaz
    Spiliopoulou, Athina
    Mcgurnaghan, Stuart J.
    Iakovliev, Andrii
    Lipschutz, Debby
    Hayward, Caroline
    Bull, Shelley B.
    Klein, Barbara E. K.
    Lee, Kristine E.
    Kinney, Gregory L.
    Rewers, Marian
    Costacou, Tina
    Miller, Rachel G.
    Mckeigue, Paul M.
    Paterson, Andrew D.
    Colhoun, Helen M.
    DIABETES, 2025, 74 (02)
  • [6] C-peptide: should we be testing this routinely in the Type 1 diabetes clinic?
    Huda, M. S. B.
    Hitman, G. A.
    DIABETIC MEDICINE, 2015, 32 (10) : 1259 - 1260
  • [7] Implementation of c-peptide testing in a hospital based type 1 diabetes clinic
    Mitchell, K.
    Connelly, P.
    Carty, D.
    Hughes, K.
    Lindsay, R. S.
    DIABETIC MEDICINE, 2020, 37 : 176 - 177
  • [8] Association of a Type 1 Diabetes Genetic Risk Score with C-Peptide and Age of Diagnosis in Type 1 Diabetes
    Roshandel, Delnaz
    Oram, Richard A.
    Hattersley, Andrew T.
    Weedon, Michael N.
    Gubitosi-Klug, Rose
    Bull, Shelley B.
    Paterson, Andrew D.
    DIABETES, 2016, 65 : A458 - A458
  • [9] Factors associated with preservation of C-peptide levels at the diagnosis of type 1 diabetes
    Szypowska, Agnieszka
    Groele, Lidia
    Wysocka-Mincewicz, Marta
    Mazur, Artur
    Lisowicz, Lucyna
    Ben-Skowronek, Iwona
    Sieniawska, Joanna
    Klonowska, Bozenna
    Charemska, Dorota
    Nawrotek, Jolanta
    Jalowiec, Irena
    Bossowski, Artur
    Noiszewska, Klaudyna
    Pyrzak, Beata
    Rogozinska, Izabela
    Szalecki, Mieczyslaw
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (06) : 570 - 574
  • [10] Response to comment on 'impact of routine clinic measurement of random serum C-peptide in people with a clinician diagnosis of type 1 diabetes' doi: 10.1111/dme.14449
    Foteinopoulou, Evgenia
    Strachan, Mark W. J.
    DIABETIC MEDICINE, 2022, 39 (01)
12345